Back

TEsingle enables locus-specific transposable element expression analysis at single-cell resolution

Forcier, T.; Cheng, E.; Tam, O. H.; Wunderlich, C.; Castilla-Vallmanya, L.; Jones, J. L.; Quaegebeur, A.; Barker, R. A.; Jakobsson, J.; Gale Hammell, M.

2026-03-22 genomics
10.64898/2026.03.19.712984 bioRxiv
Show abstract

Transposable elements (TEs) are mobile genetic sequences that can generate new copies of themselves via insertional mutations. These viral-like sequences comprise nearly half the human genome and are present in most genome wide sequencing assays. While only a small fraction of genomic TEs have retained their ability to transpose, TE sequences are often transcribed from their own promoters or as part of larger gene transcripts. Accurately assessing TE expression from each individual genomic TE locus remains an open problem in the field, due to the highly repetitive nature of these multi-copy sequences. These issues are compounded in single-cell and single-nucleus transcriptome experiments, where additional complications arise due to sparse read coverage and unprocessed mRNA introns. Here we present our tool for single-cell TE and gene expression analysis, TEsingle. Using synthetic datasets, we show the problems that arise when not properly accounting for intron retention events, failing to address uncertainty in alignment scoring, and failing to make use of unique molecular identifiers for transcript resolution. Addressing these challenges has enabled an accurate TE analysis suite that simultaneously tracks gene expression as well as locus-specific resolution of expressed TEs. We showcase the performance of TEsingle using single-nucleus profiles from substantia nigra (SN) tissues of Parkinsons Disease (PD) patients. We find examples of young and intact TEs that mark dopaminergic neurons (DA) as well as many young TEs from the LINE and ERV families that are elevated in PD neurons and glia. These results demonstrate that TE expression is highly cell-type and cellular-state specific and elevated in particular subsets of neurons, astrocytes, and microglia from PD patients.

Matching journals

The top 10 journals account for 50% of the predicted probability mass.

1
Genome Biology
555 papers in training set
Top 0.7%
8.2%
2
Nature Biotechnology
147 papers in training set
Top 0.9%
8.2%
3
NAR Genomics and Bioinformatics
214 papers in training set
Top 0.1%
7.0%
4
Genome Research
409 papers in training set
Top 0.3%
6.7%
5
eLife
5422 papers in training set
Top 18%
4.8%
6
PLOS Genetics
756 papers in training set
Top 5%
3.5%
7
Scientific Reports
3102 papers in training set
Top 39%
3.5%
8
Bioinformatics
1061 papers in training set
Top 6%
3.5%
9
Cell Genomics
162 papers in training set
Top 2%
3.5%
10
Cell Reports Methods
141 papers in training set
Top 1.0%
3.5%
50% of probability mass above
11
BMC Genomics
328 papers in training set
Top 1%
3.0%
12
Nucleic Acids Research
1128 papers in training set
Top 7%
3.0%
13
Mobile DNA
27 papers in training set
Top 0.1%
2.3%
14
PLOS ONE
4510 papers in training set
Top 49%
2.0%
15
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 30%
1.8%
16
Molecular Systems Biology
142 papers in training set
Top 0.5%
1.8%
17
Nature Communications
4913 papers in training set
Top 52%
1.7%
18
Genome Medicine
154 papers in training set
Top 5%
1.7%
19
The American Journal of Human Genetics
206 papers in training set
Top 2%
1.7%
20
Bioinformatics Advances
184 papers in training set
Top 3%
1.7%
21
iScience
1063 papers in training set
Top 17%
1.6%
22
npj Parkinson's Disease
89 papers in training set
Top 0.8%
1.3%
23
Cell Reports
1338 papers in training set
Top 28%
1.2%
24
PLOS Computational Biology
1633 papers in training set
Top 20%
1.2%
25
Nature Genetics
240 papers in training set
Top 6%
1.1%
26
Movement Disorders
62 papers in training set
Top 0.9%
0.9%
27
Brain
154 papers in training set
Top 4%
0.9%
28
Human Molecular Genetics
130 papers in training set
Top 4%
0.7%
29
Frontiers in Genetics
197 papers in training set
Top 11%
0.7%
30
Nature Methods
336 papers in training set
Top 7%
0.6%